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T he diagnosis of the etiology of a patient’s fever of unknown origin (FUO) is often challenging for 
general practice physicians,  and there are sometimes 
very limited findings directly related to the causal dis-
ease(s) of a fever.  In an outpatient unit,  it can be very 
difficult to establish a final diagnosis and initiate appro-
priate treatment within the short period of a patient’s 
visit.
Petersdorf and Beeson first proposed the classical 
definition of FUO in 1961 [1].  Their criteria included 
prolonged febrile illness of ≥ 3 weeks in duration with a 
fever > 38.3°C and the cause being uncertain after 1 
week of hospitalized investigation [1].  Durack and 
Street redefined FUO in 1991 to include,  in addition to 
classical FUO,  nosocomial,  neutropenic and HIV-
associated FUOs [2].  The original definition of classical 
FUO was modified to include fever with a cause that 
remains uncertain after a ≥ 3-day hospitalization or 
three hospital visits [2].
Since then,  studies on FUO have been carried out 
worldwide [3-7],  and several FUO studies have been 
conducted in Japan [8-13].  The latter studies investi-
gated the reduced tendency of infectious disease [14] 
and the influence of various diagnostic methods [9] on 
the diagnosis of FUOs,  including methods using fluo-
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We retrospectively analyzed the cases of 148 febrile patients whose body temperature (BT) was ≥ 37.5°C at our 
hospital.  We categorized them into seven groups; those with bacterial and viral infection,  nonspecific inflam-
mation,  neoplasm,  connective tissue disease (CTD),  drug-induced disease,  and unidentified causes.  Our 
analysis revealed that the patient’s BT at the 1st visit (BT-1st visit) and highest BT during the febrile period 
(BT-max) differed significantly among all categories except neoplasm.  The greatest difference between BT-1st 
visit and BT-max was highest in the CTD group (1.5°C).  Positive correlations of heart rate and C-reactive pro-
tein (CRP) level with BT-max and a negative correlation between serum sodium level with BT-max were uncov-
ered.  The serum thyroid-stimulating hormone (TSH) level and the ratio of TSH/free thyroxine were negatively 
correlated with BT-max,  especially in the viral infection group,  suggesting the existence of occult thyrotoxico-
sis in accord with a febrile condition,  possibly leading to febrile tachycardia.  A febrile gap between BT-1st visit 
and BT-max (except in the neoplasm group) was shown,  in which BT-max was correlated with thyroid function.  
Clinicians should recognize the fluctuation of BT when diagnosing febrile patients,  and tachycardia in such 
febrile patients may be,  at least in part,  associated with subclinical thyroid dysfunction.
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rodeoxyglucose-positron emission tomography (FDG-
PET) [10] and procalcitonin [15].  In 2013,  Naito et al.  
reported the results of the first nationwide survey on 
FUOs in Japan that examined the usefulness of inflam-
matory markers such as the white blood cell (WBC) 
count,  erythrocyte sedimentation rate (ESR),  serum 
level of C-reactive protein (CRP),  and serum level of 
procalcitonin for the diagnosis of FUO [11 , 13].
Since the criteria for classical FUO are strict,  recent 
studies have targeted a much wider spectrum of febrile 
patients [12 , 14].  A study by Goto et al.  dealt with not 
only classical FUO but also all febrile diseases with axil-
lary temperatures above 37°C,  and their analysis showed 
that the inclusion of a wider spectrum of febrile diseases 
is necessary for patients with a prolonged fever [16].  We 
also analyzed hospitalized febrile patients with axillary 
temperatures above 37.5°C in our department,  and we 
reported that disease categorization is useful for the 
diagnosis of febrile etiology [17].
Although there have been various reports on fever as 
described above,  the optimal management of a patient 
with an FUO remains difficult and necessitates an indi-
vidual evaluation for each patient and an experienced 
physician [18].  The fundamental steps of taking a med-
ical history and physical examination are still important 
[19].  In this study,  we analyzed various clinical data of 
febrile outpatients with a focus on changes in body tem-
perature (BT) and clinical and biochemical parameters.
Patients and Methods
Patients. We retrospectively analyzed the medi-
cal records of 148 febrile patients who visited the 
Department of General Medicine,  Okayama University 
Hospital during the period from January 2012 to 
December 2012.  The cases of patients with an axillary 
body temperature ≥ 37.5°C at their first visit (BT-1st 
visit) and those with a highest axillary body tempera-
ture > 37.5°C during the febrile period (BT-max) were 
included.  The patients were 75 males and 73 females 
with a mean age of 42.4 years (range 3-90 years).  The 
study protocol (#K1506-014) was approved by the 
Institutional Review Board (IRB) of the Okayama 
University Graduate School of Medicine,  Dentistry and 
Pharmaceutical Sciences.
Laboratory examination. Blood cell counts,  ESR,  
serum level of CRP,  serum levels of electrolytes includ-
ing sodium,  and the levels of total cholesterol (T.Cho),  
blood sugar (BS),  thyroid-stimulating hormone (TSH),  
and free thyroxine (FT4) were determined by an 
auto-analyzer system in the Central Laboratory of 
Okayama University Hospital.  Serum CRP levels were 
determined by a latex-agglutination method using latex 
particles conjugated with anti-CRP antiserum,  and the 
normal range was < 0.3 mg/dl.  The levels of serum TSH 
and FT4 were determined by an electrochemilumines-
cence immunoassay,  and we selected the results regard-
ing thyroid functions at the first or second visit for fever 
for the present analysis.
Statistical analysis. Results are shown as the 
mean ± SEM of the data.  The data were subjected to 
Kruskal-Wallis and Mann-Whitney U-tests to determine 
significant differences between the groups.  If differ-
ences were detected by the Kruskal-Wallis test,  the 
Steel-Dwass post-hoc test was used to determine which 
means differed.  The data were also analyzed by a linear 
regression analysis and Spearman’s rank correlation 
coefficients to determine inter-relationships between 
parameters.  P-values < 0.05 were accepted as signifi-
cant.  All statistical analyses were performed with EZR 
(Saitama Medical Center,  Jichi Medical University,  
Saitama,  Japan),  which is a graphical user interface for 
R (The R Foundation for Statistical Computing,  Vienna,  
Austria).  More precisely,  it is a modified version of R 
commander (2.3-0) designed to add statistical functions 
frequently used in biostatistics [20].
Results
Profiling of febrile outpatients. The distribution 
of the patients’ ages is shown in Fig. 1A.  Among the 
patients (aged 3-90 years),  a large proportion (58.1%) 
was relatively young (20-49 years old).  As noted above,  
the gender distribution was 75 males (50.7%) and 73 
females (49.3%).  We categorized the patients into the 
following seven groups based on our previous study [17] 
(Fig. 1B): those whose fever was attributed to (1) a bac-
terial infection (Bacterial),  (2) a viral infection (Viral),  
(3) nonspecific inflammation (NSI),  (4) a neoplasm 
(Neoplasm),  (5) connective tissue disease (CTD),  (6) 
drug-induced disease (Drug),  and (7) Unidentified.
The numbers and proportions of patients were 
Bacterial (n = 32,  21.6%),  Viral (n = 49,  33.1%),  NSI 
(n = 14,  9.5%),  Neoplasm (n = 5,  3.4%),  CTD (n = 6,  
4.05%),  Drug (n = 6,  4.05%),  and Unidentified (n = 36,  
24.3%).  The majority of the diseases was infectious dis-
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eases,  including Bacterial and Viral diseases,  which 
together accounted for 54.7% of the cases.  The female-
to-male ratio was high in the NSI (3.3) and Drug groups 
(2.5),  and the male-to-female ratio was high in the 
Viral group (2.1).
Febrile characteristics in each disease category.
The data regarding the patients’ age,  duration of fever,  
and body temperature in the 7 groups are summarized 
in Fig. 2.  The mean ages of the patients in the Neoplasm 
and CTD groups ( > 60 years) were significantly higher 
compared to the Viral group ( < 35 years) (Fig. 2A).  The 
average fever durations were significantly different 
between the Viral and Unidentified groups (Fig. 2B).  
The febrile period was longest in the Unidentified group 
( > 200 days) and shortest in the Viral group (8 days) and 
Drug group ( < 7 days).  The patients in the CTD and 
Neoplasm groups had relatively long febrile durations 
(30-50 days).  As shown in Fig. 2C,  between-group dif-
ferences in BT-1st visit and BT-max were revealed,  with 
BT-max being significantly higher than BT-1st visit in 
all groups except the Neoplasm group.
Correlations between BT and clinical parameters.
Based on the results shown in Fig. 2C,  we focused on 
the relationships between BT-max and various parame-
ters.  Fig. 3 illustrates the relationships between BT-max 
and the clinical parameters of systolic blood pressure 
(SBP),  diastolic blood pressure (DBP),  and heart rate 
(HR) for the 134 patients in whom the HR was weakly 
but significantly correlated with BT-max (r = 0.232,  
p < 0.01).  SBP and DBP were not significantly correlated 
with BT-max.
Correlations between BT and laboratory data.
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Fig. 1 Characteristics of febrile patients.  A,  Age distribution of the patients; B,  Numbers and gender ratios in the categorized diseases.  
All febrile patients were classiﬁed into 7 groups: bacterial infection (Bacterial),  viral infection (Viral),  nonspeciﬁc inﬂammation (NSI),  con-
nective tissue disease (CTD),  Neoplasm,  drug-induced disease (Drug) and Unidentiﬁed cases.  The female/male ratios are shown below.
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Fig. 2 Body temperature and fever duration.  A,  Mean ages in the categorized febrile groups (n＝148); B,  Duration of fever before 1st 
visit (n＝148); C,  Diﬀerences in body temperature at the 1st visit (BT-1st visit) and highest body temperature during the fever (BT-max) 
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Fig. 3 Relationships between high-
est body temperature (BT-max) and 
clinical parameters.  Correlations 
between body temperature and clini-
cal parameters (SBP,  DBP,  and HR) 
were statistically analyzed by linear 
regression analysis.
Fig. 4 depicts the correlations of BT-max with major 
inflammatory markers (WBC,  ESR,  and CRP) and 
metabolic markers (sodium,  T.Cho,  and BS).  The 
patients’ CRP level was positively correlated with 
BT-max (r = 0.306,  p < 0.01),  and the sodium level was 
inversely correlated with BT-max (r = −0.242,  p < 0.01).  
The levels of WBC,  ESR,  T.Cho,  and BS were not sig-
nificantly correlated with BT-max.
Correlations between BT and thyroid functions.
The relationships between BT-max and thyroid func-
tions including serum levels of TSH and FT4 and ratio 
of TSH/FT4 are shown in Fig. 5.  TSH was measured in 
64 febrile patients,  and FT4 was also measured in 61 
febrile patients including one patient with subacute thy-
roiditis,  one patient with silent thyroiditis,  and three 
patients with a past history of Graves’ disease.  We 
observed that the patients’ TSH level was negatively 
correlated with BT-max (r = −0.515,  p < 0.01) and that 
the FT4 level was positively correlated with BT-max 
(r = 0.377,  p < 0.01).  In addition,  the ratio of TSH/FT4 
was negatively correlated with BT-max (r = −0.547,  
p < 0.01).  The correlations between BT-max and TSH/
FT4 ratio for each disease category were as follows:  
Bacterial : r = −0.374,  p = 0.208 (13 cases) ; Viral :  
r=−0.672,  p=0.0473 (9 cases); CTD: r=−0.8,  p=0.333 
(4 cases); Drug: r = −0.1,  p = 0.95 (5 cases); NSI:  
r = −0.699,  p = 0.0538 (8 cases); and Unidentified:  
r = −0.37,  p = 0.0898 (22 cases).
Four patients were observed to have abnormally 
high levels of serum FT4 (Fig. 5).  One was a patient 
with bacterial prostatitis accompanying silent thyroiditis 
(in the Bacterial group),  whose serum FT4 level was 
3.95 ng/dl and BT-max was 40°C.  Another two patients 
were subacute thyroiditis (in the NSI group) and histio-
cytic necrotizing lymphadenitis accompanying Graves’ 
disease (in the NSI group),  whose serum FT4 levels 
were 2.72 and 2.93 ng/dl and BT-max were 39°C and 
38.9°C,  respectively.  The other patient’s case was thyro-
toxicosis triggered by allergic reaction (in the Drug 
group); hisserum FT4 level was 5.39 ng/dl and the 
BT-max was 38.3°C.
Discussion
We analyzed clinical data including the BT,  SBP,  
DBP,  HR and laboratory data for 148 febrile outpatients 
who visited our Department of General Medicine 
during a 1-year period.  We recently showed the useful-
ness of the categorization of febrile patients into seven 
groups [17].  Compared to the data for our inpatients,  
among the present study’s outpatients the proportion of 
patients with a non-bacterial/viral infection was higher 
and the proportion of patients with a neoplasm or CTD 
was lower: bacterial infection (21.6% in the present 
study vs. 23.6% in our inpatient data),  non-bacterial 
infection (33.1% vs. 17.8%),  NSI (9.5% vs. 14.9%),  
Neoplasm (3.4% vs. 6.9%),  CTD (4.05% vs. 12.0%),  
Drug (4.05% vs. 5.7%),  and Unidentified (24.3% vs. 
19.0%).  Patients with infectious diseases including 
Bacterial (21.6%) and Viral (33.1%) diseases accounted 
for approximately half of all patients,  suggesting that 
many of the common infectious diseases (e.g.,  upper 
respiratory tract inflammation and infectious gastro-
enteritis) were incorporated in this series of febrile out-
patients.
Regarding the patients’ profile,  the average ages of 
the patients in the Neoplasm and CTD groups were sig-
nificantly higher than the average age in the Viral group.  
The febrile period in the Viral group was significantly 
shorter than that in the Unidentified group.  The 
patients in the CTD and Neoplasm groups had a rela-
tively long febrile period ( > 30 days),  but this was sta-
tistically insignificant.
In the present study of outpatients,  the first import-
ant finding was the difference in BT as shown between 
BT-1st visit and BT-max.  The difference in BT was 
remarkable in the CTD group,  with BT-max at > 1.5°C 
higher than the BT-1st visit values.  Although there has 
been no clear report on daily BT changes in febrile 
patients,  it was noted that the BT of febrile patients 
such as patients with familial Mediterranean fever tends 
to fluctuate daily [21],  and the febrile changes between 
visits may also be influenced by antipyretics taken 
before visits.  Considering that in our series key labora-
tory data were more strongly correlated with BT-max 
than with BT-1st visit (data not shown),  clinicians 
should inquire in detail about a patient’s body tempera-
ture even if the patient does not have a fever at the time 
of his/her visit,  particularly for outpatients.
Among the laboratory parameters we examined on 
the basis of BT-max,  the serum level of CRP was weakly 
but significantly correlated with BT-max,  whereas the 
serum sodium level was negatively correlated with 
BT-max.  The correlations of BT with other biomarkers 
or clinical findings examined herein were not statisti-
cally significant.  The results regarding the correlation 
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Fig. 4 Relationships between highest body temperature (BT-max) and various biomarkers.  Correlations between body temperature and 
biomarkers (WBC,  ESR,  CRP,  Sodium,  T-Cho,  and BS) were statistically analyzed by linear regression analysis.
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between CRP and BT-max in this study and in our pre-
vious study of inpatients [17] showed similar tenden-
cies,  suggesting that the degree of inflammation shown 
by the CRP level reflects the patient’s febrile condition.
Regarding the changes in serum sodium levels,  an 
inverse relationship between sodium and febrile condi-
tion was shown [22],  implying that the BT was associ-
ated with lower sodium conditions,  possibly due to 
susceptibility to SIADH (syndrome of inappropriate 
secretion of antidiuretic hormone) induced by febrile 
stress.  The involvement of prostaglandin E2,  which acts 
on the hypothalamus to raise the BT and affects sodium 
reabsorption from the proximal tubules of the kidneys,  
might be associated with the phenomenon of febrile 
hyponatremia [23].
A second major finding revealed by our present 
investigation was the involvement of thyroid dysfunc-
tion shown by TSH/FT4 ratios in the febrile conditions 
of these outpatients.  In this patient series,  the TSH/
FT4 ratio was significantly correlated with BT-max.  
Thus far,  a correlation between fever and thyroid func-
tion has not been reported,  to our knowledge.  
Considering a report showing that a subcutaneous 
administration of interleukin-6 (IL-6) can decrease TSH 
and increase FT4 [24],  a febrile condition may stimu-
late the production of IL-6,  leading to a relatively thy-
rotoxicotic condition in vivo.
Regarding the correlation between BT-max and HR,  
it is known that the heart rate is elevated in febrile 
patients because of sympathetic enhancement [25].  
However,  it is also known that some febrile patients 
exhibit relative bradycardia caused by drug-induced 
fever,  tumor-induced fever,  specific infectious diseases,  
or other conditions [26].  Some studies have shown that 
fever may directly influence sodium channels,  causing 
tachyarrhythmia [27 , 28].  Various factors are thus 
speculated to be involved in febrile tachycardia,  but the 
mechanism of febrile tachycardia has not been clarified.  
Thyrotoxicosis is often caused by stress conditions such 
as surgery and viral infection [29 , 30].  As shown by our 
present analyses,  only the Viral group showed a signifi-
cant correlation between the BT-max and the TSH/FT4 
ratio.  Fever itself may be a stress condition and the 
cause of potential thyrotoxicosis,  leading to tachycar-
dia.
Considering that potential thyrotoxicosis accompa-
nies a febrile condition,  although a thyroid crisis is 
provoked by stress conditions such as infection and 
surgery,  fever itself may be the cause of the thyroid cri-
sis [31 , 32].  When clinicians encounter febrile patients,  
they should exclude the possibility of thyroid crisis since 
fever and tachycardia are significant symptoms of thy-
roid crisis,  and it is also important to evaluate thyroid 
findings for undiagnosed febrile patients.  Since poten-
tial thyrotoxicosis may be the cause of unpleasant sub-
jective symptoms of febrile patients such as palpitation,  
fatigue and irritability,  treatment for occult thyrotoxi-
cosis may be effective for improving unpleasant symp-
toms.
In conclusion,  our analyses revealed that a patient’s 
body temperature at the first hospital visit for fever 
(BT-1st visit) and patients’ highest body temperature 
during the febrile period (BT-max) are significantly dif-
ferent,  and that BT-max is significantly correlated with 
key parameters including thyroid function.  When clini-
cians encounter outpatients complaining of fever,  a 
detailed inquiry about the patients’ body temperature 
should be conducted,  including an examination of body 
temperature fluctuation,  since the BT-max in the febrile 
period may predict the patient’s condition more accu-
rately than the BT-1st visit.  Since the number of cases 
and detailed information regarding thyroid diseases in 
the present series are limited,  a multicenter study with 
an endocrinological investigation is necessary.  Our 
findings revealed that thyroid dysfunction occurs in 
febrile patients and that tachycardia in febrile patients 
may be,  at least in part,  associated with subclinical thy-
roid dysfunction.
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